Buprenorphine Hydrochloride Market
Buprenorphine Hydrochloride Market Global Industry Assessment & Forecast
#
Pages:
155
2021
Nov - 2021
VMR-2021-0529
Segments Covered
By
Type Tablets, Injection
-
By
Application Analgesic, Opioid Antagonist
Snapshot
 Forecast
Years:
|
2021 - 2028 |
 Historical
Years:
|
2016 - 2020 |
 Revenue
2021: |
5.05 Billion |
 Revenue 2028:
|
9.49 Billion |
 Revenue CAGR
(2021 - 2028): |
8.2 |
Fastest Growing Region (2022 -
2028)
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Research Methodology: Buprenorphine Hydrochloride Market - Global Market Assessment, 2021 - 2028
The global Buprenorphine Hydrochloride market research study is based on a comprehensive research methodology that involves 3 major activities: Secondary Research, Primary Research, and Data Triangulation. Secondary resources are utilized to gain insights on the market and later primary research is conducted to revalidate the information and conclusion derived from the secondary research. Moreover, the information procured from the secondary and primary resources is undergone through data triangulation methods to attain more accurate results on quantitative and qualitative analysis for specific market research studies.
Secondary Research
Primary Research:
The later stage covers data validation and collection from primary research. The information gained/procured from the secondary data sources is validated through extensive primary interviews with industry experts across the Buprenorphine Hydrochloride supply chain. The primary research is also conducted to identify key players in the market and to gather and validate already procured information pertaining to their market-specific financial information. Moreover, primary research is used to gain/validate information about:
- Buprenorphine Hydrochloride market size at regional and country level
- Key industry players and their market share and Buprenorphine Hydrochloride market-specific sales/revenue
- Understanding of the Buprenorphine Hydrochloride supply chain and overall ecosystem
Data Triangulation and Market Size Estimations
After arriving at the global market numbers, top-down and bottom-up approaches are used to estimate, validate and finalize the market size of the Buprenorphine Hydrochloride market. After the determination of the overall market size, the market is divided into various segments and sub-segments. Moreover, these same approaches mentioned above were used to derive and estimate market numbers for mentioned segments/sub-segments in the market. During the data triangulation process, the data was analyzed by employing various data models and statistical techniques to arrive at exact statistics and market size for each segment/sub-segment of the market. The data is analyzed and triangulated by considering all the key market impacting factors from both supply and demand side of Buprenorphine Hydrochloride market.
FAQ
Frequently Asked Question
What is the global demand for Buprenorphine Hydrochloride in terms of revenue?
-
The global Buprenorphine Hydrochloride valued at 5.05 Billion in 2020 and is expected to reach 9.49 Billion in 2028 growing at a CAGR of 8.2%.
Which are the prominent players in the market?
-
The prominent players in the market are Resonance-labs, UnichemlabsNoramco, Siegfried, Faranshimi, Johnson Matthey, Rusan Pharma, Mallinckrodt, Sanofi, Sun Pharma, Mocind, Sinopharm, Arevipharma..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 8.2% between 2021 and 2028.
What are the driving factors fueling the growth of the market?
-
The driving factors of the Buprenorphine Hydrochloride include
- The increasing opioid addiction cases are driving the growth of the buprenorphine hydrochloride market within estimated timeframe. With this, the number of reported cases of opioid addiction is increasing due to the high availability and low cost of opioids that is also likely to support the growth of the market.
- The increasing innovations and development by government in healthcare sector is expected to hinder the growth of the market in the years to come.
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Buprenorphine Hydrochloride in 2020.
